Ball Thomas M, Weydert Joy A
Department of Pediatrics and Steele Memorial Children's Research Center and Program in Integrative Medicine, University of Arizona Health Sciences Center, Tucson, AZ 85724-5073, USA.
Arch Pediatr Adolesc Med. 2003 Nov;157(11):1121-7. doi: 10.1001/archpedi.157.11.1121.
Studies evaluating the efficacy of treatments for recurrent abdominal pain (RAP) in children have used a wide range of methods, causing difficulty in the comparison of results. An expert panel on functional gastrointestinal disorders recently made recommendations regarding the standardization of study methods for childhood RAP, but many of their recommendations remain untested or lack supportive evidence.
During completion of a pilot study and randomized controlled trial for childhood RAP, baseline data were collected regarding the child and parent reports of abdominal pain frequency and intensity, type of abdominal pain, missed activities due to abdominal pain, psychological factors for the parent and child, parenting styles, and referral source (pediatric gastroenterologist vs general pediatrician).
Children and parent pain reports showed good agreement in children younger than 13 years (weighted kappa, 0.77; 95% confidence interval [CI], 0.71-0.84), but only marginal agreement in children 13 years or older (weighted kappa, 0.37; 95% CI, 0.30-0.45). We found no significant differences in pain characteristics or psychological factors between children referred by pediatric gastroenterologists in a tertiary care center and those referred by community-based primary care pediatricians. However, children with symptoms consistent with nonspecific functional abdominal pain were reported by their parents to have less frequent pain (P=.003) and fewer missed activities (P=.003) than children with symptoms of irritable bowel syndrome or functional dyspepsia.
Subjects referred by gastroenterologists and general pediatricians were similar, but the subtype of functional gastrointestinal disorder might be an important baseline characteristic of subjects in future RAP studies. We suggest that future interventional studies of childhood RAP measure 2 outcomes with pain reports obtained directly from children. Any child with fewer days of pain and missed activities due to pain after therapy would be considered improved, and those with no missed activities and 4 or fewer days of pain per month at follow-up would be considered healed.
评估儿童复发性腹痛(RAP)治疗效果的研究采用了多种方法,导致结果比较困难。一个功能性胃肠疾病专家小组最近就儿童RAP研究方法的标准化提出了建议,但其中许多建议仍未得到检验或缺乏支持证据。
在完成一项儿童RAP的试点研究和随机对照试验期间,收集了关于儿童和家长报告的腹痛频率和强度、腹痛类型、因腹痛错过的活动、家长和儿童的心理因素、养育方式以及转诊来源(儿科胃肠病学家与普通儿科医生)的基线数据。
13岁以下儿童的儿童和家长疼痛报告显示出良好的一致性(加权kappa值为0.77;95%置信区间[CI],0.71 - 0.84),但13岁及以上儿童仅显示出微弱的一致性(加权kappa值为0.37;95%CI,0.30 - 0.45)。我们发现,三级医疗中心的儿科胃肠病学家转诊的儿童与社区基层医疗儿科医生转诊的儿童在疼痛特征或心理因素方面没有显著差异。然而,与肠易激综合征或功能性消化不良症状的儿童相比,家长报告有非特异性功能性腹痛症状的儿童疼痛频率更低(P = 0.003),错过的活动更少(P = 0.003)。
胃肠病学家和普通儿科医生转诊的受试者相似,但功能性胃肠疾病的亚型可能是未来RAP研究中受试者的一个重要基线特征。我们建议,未来儿童RAP的干预性研究应通过直接从儿童获得的疼痛报告来衡量2个结果。任何在治疗后因疼痛而疼痛天数减少且错过活动减少的儿童都将被视为有所改善,而那些在随访时没有错过活动且每月疼痛天数为4天或更少的儿童将被视为治愈。